Lido Advisors LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 32.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,095 shares of the company’s stock after buying an additional 1,010 shares during the period. Lido Advisors LLC’s holdings in Colgate-Palmolive were worth $309,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Renaissance Technologies LLC grew its stake in shares of Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after purchasing an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. grew its stake in shares of Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock worth $296,557,000 after purchasing an additional 2,884,100 shares during the last quarter. Harding Loevner LP grew its stake in shares of Colgate-Palmolive by 92.0% in the 3rd quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after purchasing an additional 2,272,675 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after purchasing an additional 1,750,417 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares during the last quarter. 73.87% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Colgate-Palmolive (NYSE CL) opened at $69.62 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. The company has a market cap of $60,887.72, a P/E ratio of 30.54, a P/E/G ratio of 2.58 and a beta of 0.79. Colgate-Palmolive has a fifty-two week low of $68.19 and a fifty-two week high of $77.91.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting the consensus estimate of $0.75. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company posted $0.75 earnings per share. analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be issued a dividend of $0.42 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.41%. The ex-dividend date of this dividend is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 70.18%.
Several equities analysts have recently issued reports on the stock. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 26th. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Barclays set a $75.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Thursday. Finally, Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $77.71.
In related news, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the sale, the insider now directly owns 37,788 shares in the company, valued at $2,865,086.16. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CTO Patricia Verduin sold 1,572 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $70.17, for a total transaction of $110,307.24. Following the sale, the chief technology officer now owns 50,675 shares of the company’s stock, valued at $3,555,864.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 455,707 shares of company stock valued at $32,443,427. 1.02% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This article was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://ledgergazette.com/2018/03/17/colgate-palmolive-cl-shares-bought-by-lido-advisors-llc.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.